Cancer is one of the leading causes of death worldwide. According to the World Health Organization, about 8.2 million deaths occurred in 2012 due to cancer. The most common kinds of cancer which tend to result in death are lung cancer, liver cancer, stomach cancer, colorectal cancer, breast cancer and oesophageal cancer. Apart from the mature chemotherapy market, biotherapy has emerged as a new approach for cancer treatment. Biotherapy boosts the body’s immune system to slow or stop the growth of cancer cells. Growing demand for personalized medicine and the introduction of novel approaches are expected to drive the market growth. Astra Zeneca PLC, Biogen IDEC, Bristol-Myers Squibb, Sanofi, Merck, Johnson & Johnson, Schering-Plough and Roche are some players in this market.
The cancer therapeutics and biotherapeutic market is segmented into technology and geography. On the basis of technology, the market is segmented into Chemotherapy, radiation therapy, hormonal therapy and biotherapy. Chemotherapy includes alkylating agents, cytotoxic agents, antimetabolites, plant derivatives and others. Radiation therapy comprises of Intraoperative radiotherapy, external beam radiation therapy, brachytherapy and radioisotope therapy. Hormonal therapy consists of hormone antagonists, corticosteroids, aromatase inhibitors, and selective estrogen receptor modulators (SERMs.) Biotherapy includes monoclonal antibodies, interleukins, kinases and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA.
Key Market Segments
Market by Technology
Market by Geography
SIMILAR MARKET STUDIES
The 2017-2022 Bio Pharma Buffer Report on Global and United States Market, Status and Forecast, by Players, Types and Applications is a professional and in-depth study on the current state of the Bio Pharma Buffer market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a ...
September 2017 | $2960 | View Details >>
In the last several years, China market of Vitamin D Testing developed rapidly, with an average growth rate of 17.90%. In 2016, China Revenue of Vitamin D Testing is nearly 80.68 M USD, will continue growth at 16.01% in 2022 the market of Vitamin D Testing will at 196.66 M ...
September 2017 | $3200 | View Details >>
Currently, some companies in the world can produce Artificial Tear product, mainly concentrating in North America. The main market players are Allergan, Alcon (Novartis), Bausch & Lomb, Abbott, Santen Pharmaceutical, Ursapharm Rohto, etc. The sales volume of Artificial Tear in EMEA increased from 141.16 Million Unit in 2012 to 203.70 ...
September 2017 | $4000 | View Details >>
This report studies the Cardiac Care Medical Equipment market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Cardiac Care Medical Equipment market by product type and ...
September 2017 | $2900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research